Updated Jul 16, 2026
Snider William has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $104K.

William Snider is listed as a director of Harvard Bioscience Inc (HBIO) in SEC filings with the CIK 0001340831, with the most recent filing dated 2025-12-31. Harvard Bioscience is a developer, manufacturer, and seller of scientific instruments for life sciences research and drug development. Based on the SEC context, Snider has no reported purchases or sales in the filing and serves in a governance role for HBIO.
| Role | Director |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-11 | HBIO | HARVARD BIOSCIENCE INC | A — Grant or award | 16.6K | $0.00 | |
| 2026-03-18 | HBIO | HARVARD BIOSCIENCE INC | P — Open-market purchase | 8.5K | $4.85 | $41K |
| 2026-03-18 | HBIO | HARVARD BIOSCIENCE INC | P — Open-market purchase | 12.5K | $4.99 | $62K |
| 2025-12-31 | HBIO | HARVARD BIOSCIENCE INC | A — Grant or award | 110.0K | $0.00 |
William Snider is listed as a director of Harvard Bioscience Inc (HBIO) in SEC filings with the CIK 0001340831, with the most recent filing dated 2025-12-31. Harvard Bioscience is a developer, manufacturer, and seller of scientific instruments for life sciences research and drug development. Based on the SEC context, Snider has no reported purchases or sales in the filing and s…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 2 open-market purchases ($104K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Snider William profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.